DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells

Defining new therapeutic strategies to overcome therapy resistance due to tumor heterogeneity in colon cancer is challenging. One option is to explore the molecular profile of aggressive disseminating tumor cells. The cytoskeleton-associated Death-associated protein kinase (DAPK) is involved in the cross talk between tumor and immune cells at the invasion front of colorectal cancer. Here dedifferentiated tumor cells histologically defined as tumor budding are associated with a high risk of metastasis and poor prognosis. Analyzing samples from 144 colorectal cancer patients we investigated immunhistochemical DAPK expression in different tumor regions such as center, invasion front, and buds. Functional consequences for tumor aggressiveness were studied in a panel of colon tumor cell lines using different migration, wound healing, and invasion assays. DAPK levels were experimentally modified by siRNA transfection and overexpression as well as inhibitor treatments. We found that DAPK expression was reduced towards the invasion front and was nearly absent in tumor buds. Applying the ECIS system with HCT116 and HCT116 stable lentiviral DAPK knock down cells (HCTshDAPK) we identified an important role for DAPK in decreasing the migratory capacity whereas proliferation was not affected. Furthermore, the migration pattern differed with HCTshDAPK cells showing a cluster-like migration of tumor cell groups. DAPK inhibitor treatment revealed that the migration rate was independent of DAPK's catalytic activity. Modulation of DAPK expression level in SW480 and DLD1 colorectal cancer cells significantly influenced wound closure rate. DAPK seems to be a major player that influences the migratory capability of disseminating tumor cells and possibly affects the dynamic interface between pro- and anti-survival factors at the invasion front of colorectal cancer. This interesting and new finding requires further evaluation.

[1]  Correction: miR-103/107 Promote Metastasis of Colorectal Cancer by Targeting the Metastasis Suppressors DAPK and KLF4. , 2017, Cancer research.

[2]  I. Zlobec,et al.  A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies , 2014, Journal of visualized experiments : JoVE.

[3]  V. Díaz,et al.  Regulation of the protein stability of EMT transcription factors , 2014, Cell adhesion & migration.

[4]  H. Bessler,et al.  Modulators affecting the immune dialogue between human immune and colon cancer cells. , 2014, World journal of gastrointestinal oncology.

[5]  I. Zlobec,et al.  The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome , 2014, Histopathology.

[6]  R. Schneider-Stock.  Death-associated kinase (DAPK): a cancer “gene chameleon” , 2014, Apoptosis.

[7]  R. Schneider-Stock,et al.  DAPK and cytoskeleton-associated functions , 2014, Apoptosis.

[8]  Tien Anh Nguyen,et al.  Microfluidic chip with integrated electrical cell-impedance sensing for monitoring single cancer cell migration in three-dimensional matrixes. , 2013, Analytical chemistry.

[9]  B. Fabry,et al.  Identification of DAPK as a scaffold protein for the LIMK/cofilin complex in TNF-induced apoptosis. , 2013, The international journal of biochemistry & cell biology.

[10]  A. Ishida-Yamamoto,et al.  Intercellular contact augments epidermal growth factor receptor (EGFR) and signal transducer and activator of transcription 3 (STAT3)-activation which increases podoplanin-expression in order to promote squamous cell carcinoma motility. , 2013, Cellular signalling.

[11]  M. Vieth,et al.  Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells. , 2013, The American journal of pathology.

[12]  E. Patsouris,et al.  Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer , 2013, Modern Pathology.

[13]  M. Pawlita,et al.  High‐throughput SNP‐based authentication of human cell lines , 2013, International journal of cancer.

[14]  E. Elinav,et al.  Analysis of microbiota alterations in inflammasome-deficient mice. , 2013, Methods in molecular biology.

[15]  A. Kimchi,et al.  Biochemical and functional characterization of the ROC domain of DAPK establishes a new paradigm of GTP regulation in ROCO proteins. , 2012, Biochemical Society transactions.

[16]  H. Christiansen,et al.  DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions , 2012, Apoptosis.

[17]  Hsien-Da Huang,et al.  miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. , 2012, Cancer research.

[18]  L. Terracciano,et al.  Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer. , 2011, Human pathology.

[19]  M. Koch,et al.  Invasion front‐specific expression and prognostic significance of microRNA in colorectal liver metastases , 2011, Cancer science.

[20]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[21]  J. Galon,et al.  Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. , 2011, Cancer research.

[22]  Jongin Hong,et al.  Electrical cell-substrate impedance sensing as a non-invasive tool for cancer cell study. , 2011, The Analyst.

[23]  I. Zlobec,et al.  Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget , 2010, Oncotarget.

[24]  T. Bai,et al.  Death-associated protein kinase is essential for the survival of various types of uterine cancer cells. , 2010, International journal of oncology.

[25]  I. Zlobec,et al.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. , 2009, World journal of gastroenterology.

[26]  S. Subramaniam,et al.  Chemoattractant Signaling between Tumor Cells and Macrophages Regulates Cancer Cell Migration, Metastasis and Neovascularization , 2009, PloS one.

[27]  R. Schneider-Stock,et al.  RETRACTED: Identification of phosphorylated p38 as a novel DAPK-interacting partner during TNFalpha-induced apoptosis in colorectal tumor cells. , 2009, The American journal of pathology.

[28]  S. Reu,et al.  p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumors. , 2009, Gastroenterology.

[29]  Stefan Roepcke,et al.  Genome-wide expression patterns of invasion front, inner tumor mass and surrounding normal epithelium of colorectal tumors , 2007, Molecular Cancer.

[30]  L. Terracciano,et al.  Role of APAF‐1, E‐cadherin and peritumoural lymphocytic infiltration in tumour budding in colorectal cancer , 2007, The Journal of pathology.

[31]  P. Malfertheiner,et al.  Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression. , 2007, Neoplasia.

[32]  M. Vieth,et al.  DAPK promotor methylation is an early event in colorectal carcinogenesis. , 2006, Cancer letters.

[33]  A. Kimchi,et al.  The death-associated protein kinases: structure, function, and beyond. , 2006, Annual review of biochemistry.

[34]  R. Schneider-Stock,et al.  Close localization of DAP‐kinase positive tumour‐associated macrophages and apoptotic colorectal cancer cells , 2006, The Journal of pathology.

[35]  Ruey-Hwa Chen,et al.  The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway , 2006, The Journal of cell biology.

[36]  A. Kimchi,et al.  DAPk Protein Family and Cancer , 2006, Autophagy.

[37]  A. Kimchi,et al.  DAP-kinase-mediated morphological changes are localization dependent and involve myosin-II phosphorylation , 2004, Cell Death and Differentiation.

[38]  Jia-Ren Lin,et al.  Uncoordinated regulation of stress fibers and focal adhesions by DAP kinase , 2003, Journal of Cell Science.

[39]  M. Humphries.  Faculty Opinions recommendation of Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. , 2003 .

[40]  R. Liddington,et al.  Structural determinants of integrin recognition by talin. , 2003, Molecular cell.

[41]  David A. Calderwood,et al.  The Phosphotyrosine Binding-like Domain of Talin Activates Integrins* , 2002, The Journal of Biological Chemistry.

[42]  G. Niedobitek,et al.  The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. , 2001, The American journal of pathology.

[43]  J. Bertoglio,et al.  Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing , 2001, Nature Cell Biology.

[44]  Jason C. Mills,et al.  Apoptotic Membrane Blebbing Is Regulated by Myosin Light Chain Phosphorylation , 1998, The Journal of cell biology.

[45]  S. Polak‐Charcon,et al.  DAP kinase links the control of apoptosis to metastasis , 1997, Nature.

[46]  A. Kimchi,et al.  Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. , 1995, Genes & development.

[47]  A. Hamburger,et al.  Primary bioassay of human tumor stem cells. , 1977, Science.

[48]  M. Avantaggiati,et al.  The International Journal of Biochemistry & Cell Biology , 2015 .